ERBB2 and neoplasm: Recently, Her2-specific CAR NK cells, derived from the human NK cell line NK-92, have been reported to specifically lyse GBM-derived cell lines and to show in vivo anti-tumor activity in xenografts and immunocompetent mouse models [38].